The Latin America, Middle East and Africa Analgesics Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).
Analgesics have observed a large increase in the demand over the years due to the rising therapeutic benefits they provide, as well as effective and quick pain relief. The analgesics market has also benefited from the introduction of novel medications and increased knowledge of these treatment options. Furthermore, a surge in the incidence of recurring aches and pains as a result of a rise in the frequency of cancer, arthritis, cardiovascular disease, and other chronic and acute disorders has boosted analgesic demand. The rising prevalence of pain worldwide, the growth in effective treatment choices, and the growing adoption of analgesics by a wider target audience are all factors that are positively impacting the analgesics market.
The United Arab Emirates (UAE) has one of the world's fastest-growing economies, resulting in an increase in non-communicable diseases including cancer. Despite early detection and screening measures that seems to fall short of the target population's coverage goal, the number of detected cases along with deaths in the UAE has been increasing over time. In a single article, the NCBI, or National Center for Biotechnology Information, highlighted key features of a proposed UAE national cancer management plan. The concept is currently being developed and has not yet been formally adopted. For a thorough and effective management strategy, a reliable cancer registry, accurate data, and periodic monitoring and evaluation are all essential. In addition, the UAE's cancer management strategy is being established in accordance with EMRO and WHO recommendations, with specific goals and objectives in mind. The objectives are to combat cancer, reduce its occurrence, regulate mortality, and improve the outcomes and quality of life of cancer patients. Prevention, early detection, quick diagnosis, continuity of care, treatment facilitation, performance evaluation, and research are primary objectives.
The Brazil market dominated the LAMEA Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $999.8 Million by 2028. The Argentina market is estimated to grow at a CAGR of 9.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8.5% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Analgesics Market is Predict to reach $42.6 Billion by 2028, at a CAGR of 6.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
By Type
By Route of Administration
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 